Management of Subcutaneous Abscesses

Introduction to Treatment Approaches

For subcutaneous abscesses less than 3 cm with peripheral enhancement, antibiotic therapy alone is appropriate as first-line treatment, while abscesses larger than 3 cm generally require drainage in addition to antibiotics, as recommended by the American College of Radiology and American Family Physician 1, 2

The American College of Radiology recommends antibiotic therapy alone as first-line treatment for small abscesses (<3 cm), with consideration of needle aspiration to guide antibiotic therapy if symptoms persist 1
For larger abscesses (>3 cm), percutaneous catheter drainage (PCD) plus antibiotics is the recommended first-line treatment, with surgical drainage considered if PCD is not feasible 1, 2
The size range of 3-6 cm is generally accepted as the reasonable limit between antimicrobial therapy versus percutaneous drainage in the management of abscesses, despite the low level of evidence, as specified by the 2017 WSES guidelines 3

Empiric therapy should cover Gram-positive, Gram-negative, and anaerobic bacteria, with common options including amoxicillin/clavulanate and vancomycin for MRSA-suspected cases, as suggested by the World Journal of Emergency Surgery 4
Recommended antibiotic regimens include:
Antibiotic Dosage
Amoxicillin/Clavulanate 2g/0.2g every 8 hours
Eravacycline 1mg/kg every 12 hours
Tigecycline 100mg loading dose then 50mg every 12 hours
The duration of antibiotic therapy is directly tied to adequate source control, with shorter courses (4 days) effective when adequate drainage is achieved, and longer courses (up to 7 days) considered for immunocompromised or critically ill patients, as suggested by the World Health Organization and the Infectious Diseases Society of America 5, 6

Antibiotic	Dosage
Amoxicillin/Clavulanate	2g/0.2g every 8 hours
Eravacycline	1mg/kg every 12 hours
Tigecycline	100mg loading dose then 50mg every 12 hours

Perianal and perirectal abscesses typically require drainage regardless of size, and patient factors such as immunocompromised status, systemic signs of infection, and comorbidities may lower the threshold for drainage, according to the World Journal of Emergency Surgery 4
Immunocompromised patients or those with critical illness may require more aggressive management, including longer antibiotic therapy and closer monitoring, as recommended by the Infectious Diseases Society of America and the World Health Organization 7, 8, 5

Treatment failure occurs in approximately 20-25% of cases treated with antibiotics alone, requiring subsequent drainage, as reported by the World Journal of Emergency Surgery 3
Patients should be assessed for resolution of fever, improvement in pain and trismus, decreased swelling, and normalization of laboratory markers (such as white blood cell count, C-reactive protein, and procalcitonin), as recommended by the European Society of Clinical Microbiology and Infectious Diseases 5
Ongoing signs of infection or systemic illness beyond 7 days warrant diagnostic investigation, including consideration of imaging (CT) to rule out persistent or spreading infection, and multidisciplinary re-evaluation 5
Regular assessment of clinical symptoms, laboratory markers, and imaging is necessary to confirm resolution and monitor for signs of progression, with recurrence rates potentially high (up to 44% for certain types of abscesses) 5, 9

Septic shock requires more aggressive antibiotic therapy with carbapenems or other broad-spectrum agents, while aminoglycosides are not recommended as first-line therapy due to their narrow therapeutic range and potential for ototoxicity and nephrotoxicity 5, 10
Watchful waiting can be an appropriate management strategy for small abscesses with minimal symptoms, if the patient declines drainage, provided there are no signs of systemic infection or immunocompromise, as suggested by the World Society of Emergency Surgery 7
The timing of surgical drainage for anorectal abscesses should be based on the presence and severity of sepsis, with outpatient management considered for "fit, immunocompetent patients with a small perianal abscess and without systemic signs of sepsis" 9